News
LPAAW
0.1401
0.00%
0.0000
Launch One Acquisition Corp. Shareholders Approve Extension Plan
TipRanks · 07/13 22:01
Launch One Acquisition's Shareholders Approve Extension Of Business Combination Deadline To January 15, 2027
Benzinga · 07/13 21:26
Launch One Converts Sponsor Shares to Class A Stock
TipRanks · 07/07 10:31
Launch One Acquisition Reschedules Meeting to Extend Combination Deadline
TipRanks · 06/25 21:15
Launch One Acquisition Secures New Sponsor Funding Facility
TipRanks · 03/26 20:46
Launch One Acquisition, Minovia deal terminated; new target sought
TipRanks · 02/04 11:33
Minovia Therapeutics Granted Two New U.S. Patents For Its IP Portfolio
Benzinga · 01/13 14:57
Minovia’s mitochondrial augmentation tech to be featured at ASH meeting
TipRanks · 11/20/2025 13:50
Minovia to Go Public Through Combination With SPAC
Dow Jones · 10/15/2025 11:51
Minovia receives Orphan Drug Designation for MNV-201 in MDS
TipRanks · 10/15/2025 11:35
FDA Grants Orphan Drug Designation To Minovia Therapeutic's Lead Investigational Compound, MNV-201 For Myelodysplastic Syndrome
Benzinga · 10/15/2025 11:32
Press Release: Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
Dow Jones · 10/15/2025 11:30
Press Release: Minovia Therapeutics Receives FDA -2-
Dow Jones · 10/15/2025 11:30
Minovia receives Fast Track Designation for MNV-201 in MDS
TipRanks · 09/18/2025 11:35
Press Release: Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
Dow Jones · 09/18/2025 11:30
Press Release: Minovia Therapeutics Receives FDA -2-
Dow Jones · 09/18/2025 11:30
Weekly Report: what happened at LPAA last week (0908-0912)?
Weekly Report · 09/15/2025 12:22
More
Webull provides a variety of real-time LPAAW stock news. You can receive the latest news about Launch One Acquisition Corp through multiple platforms. This information may help you make smarter investment decisions.
About LPAAW
Launch One Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It has not selected any business combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It has no operations nor generated any revenues.